These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 35958018)
1. The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis. Jamialahmadi T; Baratzadeh F; Reiner Ž; Mannarino MR; Cardenia V; Simental-Mendía LE; Pirro M; Watts GF; Sahebkar A Oxid Med Cell Longev; 2022; 2022():7850659. PubMed ID: 35958018 [TBL] [Abstract][Full Text] [Related]
2. The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Jamialahmadi T; Baratzadeh F; Reiner Ž; Simental-Mendía LE; Xu S; Susekov AV; Santos RD; Sahebkar A Mediators Inflamm; 2021; 2021():9661752. PubMed ID: 34526854 [TBL] [Abstract][Full Text] [Related]
3. The effect of nuts consumption on circulating oxidized low-density lipoproteins: A systematic review and meta-analysis of randomized controlled trials. Abbasifard M; Jamialahmadi T; Reiner Ž; Eid AH; Sahebkar A Phytother Res; 2023 Apr; 37(4):1678-1687. PubMed ID: 36856053 [TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
5. Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk. Yanai H; Adachi H; Hakoshima M; Katsuyama H Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362288 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of Statin/Ezetimibe for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Asian Populations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Bhagavathula AS; Aldhaleei WA; Al Matrooshi NO; Rahmani J Clin Drug Investig; 2020 Sep; 40(9):809-826. PubMed ID: 32671595 [TBL] [Abstract][Full Text] [Related]
7. Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease. Ndrepepa G; Braun S; von Beckerath N; Mehilli J; Gorchakova O; Vogt W; Schömig A; Kastrati A Clin Chim Acta; 2005 Oct; 360(1-2):178-86. PubMed ID: 15993392 [TBL] [Abstract][Full Text] [Related]
8. Statin therapy and plasma vitamin E concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials. Sahebkar A; Simental-Mendía LE; Ferretti G; Bacchetti T; Golledge J Atherosclerosis; 2015 Dec; 243(2):579-88. PubMed ID: 26539697 [TBL] [Abstract][Full Text] [Related]
9. Does statin therapy reduce plasma VEGF levels in humans? A systematic review and meta-analysis of randomized controlled trials. Sahebkar A; Ponziani MC; Goitre I; Bo S Metabolism; 2015 Nov; 64(11):1466-76. PubMed ID: 26347012 [TBL] [Abstract][Full Text] [Related]
10. Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1. A systematic review and meta-analysis of randomised controlled trials. Sahebkar A; Catena C; Ray KK; Vallejo-Vaz AJ; Reiner Ž; Sechi LA; Colussi G Thromb Haemost; 2016 Jul; 116(1):162-71. PubMed ID: 27009446 [TBL] [Abstract][Full Text] [Related]
11. Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study. Choi SH; Chae A; Miller E; Messig M; Ntanios F; DeMaria AN; Nissen SE; Witztum JL; Tsimikas S J Am Coll Cardiol; 2008 Jul; 52(1):24-32. PubMed ID: 18582631 [TBL] [Abstract][Full Text] [Related]
12. The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials. Qu H; Meng YY; Chai H; Liang F; Zhang JY; Gao ZY; Shi DZ Eur J Med Res; 2018 Nov; 23(1):57. PubMed ID: 30414615 [TBL] [Abstract][Full Text] [Related]
13. Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events. Singh P; Goncalves I; Tengryd C; Nitulescu M; Persson AF; To F; Bengtsson E; Volkov P; Orho-Melander M; Nilsson J; Edsfeldt A Cardiovasc Diabetol; 2020 Dec; 19(1):214. PubMed ID: 33317535 [TBL] [Abstract][Full Text] [Related]
15. Head-to-head comparison of fibrates versus statins for elevation of circulating adiponectin concentrations: a systematic review and meta-analysis. Sahebkar A Metabolism; 2013 Dec; 62(12):1876-85. PubMed ID: 24095632 [TBL] [Abstract][Full Text] [Related]
16. Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice. Smook ML; van Leeuwen M; Heeringa P; Damoiseaux JG; Theunissen R; Daemen MJ; Lutgens E; Tervaert JW Clin Exp Immunol; 2008 Nov; 154(2):264-9. PubMed ID: 18778362 [TBL] [Abstract][Full Text] [Related]
17. Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials. Sahebkar A; Simental-Mendía LE; Pedone C; Ferretti G; Nachtigal P; Bo S; Derosa G; Maffioli P; Watts GF Br J Clin Pharmacol; 2016 May; 81(5):807-18. PubMed ID: 26624855 [TBL] [Abstract][Full Text] [Related]
18. A Systematic Review and Meta-Analysis of Controlled Trials on the Effects of Statin and Fibrate Therapies on Plasma Homocysteine Levels. Sahebkar A; Pirro M; Reiner Ž; Cicero A; Ferretti G; Simental-Mendía M; Simental-Mendía LE Curr Med Chem; 2016; 23(39):4490-4503. PubMed ID: 27748179 [TBL] [Abstract][Full Text] [Related]
19. Impact of Statin Therapy on Plasma Vitamin D Levels: A Systematic Review and Meta-Analysis. Sahebkar A; Reiner Z; Simental-Mendia LE; Ferretti G; Della Corte C; Nobili V Curr Pharm Des; 2017; 23(6):861-869. PubMed ID: 27719645 [TBL] [Abstract][Full Text] [Related]